{"transactions":[{"id":1858257,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:14:49.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":18400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 8, 2023 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":18400,"derivative":{"exercise_price":24.84,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":18400},"source":{"system":"sec-edgar","filing":"0001610717-23-000132","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071723000132/form4.xml","form_type":"4"}},{"id":1858256,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-12T20:14:49.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,406 Restricted Stock Units."}],"balance_after":21251,"source":{"system":"sec-edgar","filing":"0001610717-23-000132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071723000132/form4.xml","form_type":"4"}},{"id":1874290,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-30T21:09:03.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":92958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of the Company on December 16, 2022, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended (the \"Plan\"), increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2023, at the 2023 Annual Meeting of the Company's shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 equal quarterly installments commencing on March 16, 2023."}],"balance_after":150000,"derivative":{"exercise_price":3.37,"exercise_date":"2023-03-16","expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":92958},"source":{"system":"sec-edgar","filing":"0001213900-23-044088","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390023044088/ownership.xml","form_type":"4"}},{"id":1938906,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-25T00:17:56.000Z","date":"2023-03-22","kind":"grant","planned":false,"acquired":true,"shares":432738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the stock option shall vest on March 13, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":432738,"derivative":{"exercise_price":5.04,"expiration_date":"2033-03-22","underlying":"Common Stock","underlying_shares":432738},"source":{"system":"sec-edgar","filing":"0001593968-23-000527","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000159396823000527/primary_01.xml","form_type":"4"}},{"id":1938905,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-25T00:17:56.000Z","date":"2023-03-22","kind":"grant","planned":false,"acquired":true,"shares":558094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 429,303 of performance RSUs which shall vest as follows: (1) 50% shall vest if the 30-day weighted average stock price is equal to or greater than $18 and (2) 50% shall vest upon the first regulatory approval of a product candidate. Notwithstanding the foregoing (1) any portion that vests upon the stock price threshold shall no longer vest and be terminated after three years from the grant date if such threshold has not been met in such three-year period, and (2) any portion that vests upon product candidate approval shall no longer vest and be terminated after five years from the grant date if such approval has not occurred in such five-year period."}],"balance_after":862439,"source":{"system":"sec-edgar","filing":"0001593968-23-000527","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000159396823000527/primary_01.xml","form_type":"4"}},{"id":1949518,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-16T21:08:11.000Z","date":"2023-03-14","kind":"tax_withholding","acquired":false,"shares":35879,"price":5.47,"value":196258.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.46 to $5.495, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 320 and 2000 share of the Issuer's common stock acquired by the reporting person on September 15, 2021 and on March 15, 2023 pursuant to an employee stock purchase program, respectively."}],"balance_after":304345,"source":{"system":"sec-edgar","filing":"0001737287-23-000024","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728723000024/primary_doc.xml","form_type":"4"}},{"id":2079461,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-12-20T22:33:28.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":57042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 equal quarterly installments commencing on March 16, 2023."}],"balance_after":57042,"derivative":{"exercise_price":3.37,"exercise_date":"2023-03-16","expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":57042},"source":{"system":"sec-edgar","filing":"0001213900-22-081478","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390022081478/ownership.xml","form_type":"4"}},{"id":2226597,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T21:04:44.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":18400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 16, 2022 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":18400,"derivative":{"exercise_price":16.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":18400},"source":{"system":"sec-edgar","filing":"0001567619-22-013110","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761922013110/doc1.xml","form_type":"4"}},{"id":2226596,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T21:04:44.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 8,215 Restricted Stock Units."}],"balance_after":16051,"source":{"system":"sec-edgar","filing":"0001567619-22-013110","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761922013110/doc1.xml","form_type":"4"}},{"id":2254904,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-26T22:41:00.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":91235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of the Company on December 17, 2021, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan (the \"Plan\") increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2022, at the 2022 Annual Meeting of the Company's shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 equal quarterly installments, at 6.25% per quarter, commencing on March 17, 2022."}],"balance_after":150000,"derivative":{"exercise_price":19.03,"exercise_date":"2022-03-17","expiration_date":"2031-12-17","underlying":"Common Stock","underlying_shares":91235},"source":{"system":"sec-edgar","filing":"0001213900-22-029834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390022029834/ownership.xml","form_type":"4"}},{"id":2317433,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-25T21:49:56.000Z","date":"2022-03-23","kind":"grant","acquired":true,"shares":368589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter"}],"balance_after":368589,"derivative":{"exercise_price":9.69,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":368589},"source":{"system":"sec-edgar","filing":"0001214659-22-004371","document":"marketforms-55856.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465922004371/marketforms-55856.xml","form_type":"4"}},{"id":2317432,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-25T21:49:56.000Z","date":"2022-03-23","kind":"grant","acquired":true,"shares":237358,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":337904,"source":{"system":"sec-edgar","filing":"0001214659-22-004371","document":"marketforms-55856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465922004371/marketforms-55856.xml","form_type":"4"}},{"id":2326020,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-17T21:58:47.000Z","date":"2022-03-15","kind":"sale","acquired":false,"shares":11469,"price":7.6337,"value":87550.9053,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.59 to $7.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1021 shares of the Issuer's common stock acquired by the reporting person on March 15, 2022 pursuant to an employee stock purchase program."}],"balance_after":100546,"source":{"system":"sec-edgar","filing":"0001214659-22-004084","document":"marketforms-55819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465922004084/marketforms-55819.xml","form_type":"4"}},{"id":2462121,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-22T02:31:03.000Z","date":"2021-12-17","kind":"grant","acquired":true,"shares":58765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 equal quarterly installments commencing on March 17, 2022."}],"balance_after":58765,"derivative":{"exercise_price":19.03,"exercise_date":"2022-03-17","expiration_date":"2031-12-17","underlying":"Common Stock","underlying_shares":58765},"source":{"system":"sec-edgar","filing":"0001213900-21-066823","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390021066823/ownership.xml","form_type":"4"}},{"id":2655489,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-24T21:17:20.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":12659,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 22, 2021 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":12659,"derivative":{"exercise_price":32.93,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":12659},"source":{"system":"sec-edgar","filing":"0001567619-21-012591","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761921012591/doc1.xml","form_type":"4"}},{"id":2655488,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T21:17:20.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":3617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 9,043 Restricted Stock Units."}],"balance_after":10851,"source":{"system":"sec-edgar","filing":"0001567619-21-012591","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761921012591/doc1.xml","form_type":"4"}},{"id":2694578,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-26T12:00:15.000Z","date":"2021-05-24","kind":"exercise","acquired":false,"shares":14897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option shall vest on the first anniversary of the grant date, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":94703,"derivative":{"exercise_price":18.22,"expiration_date":"2030-03-18","underlying":"Common Stock","underlying_shares":14897},"source":{"system":"sec-edgar","filing":"0001214659-21-005926","document":"marketforms-52930.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465921005926/marketforms-52930.xml","form_type":"4"}},{"id":2694577,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T12:00:15.000Z","date":"2021-05-24","kind":"exercise","acquired":true,"shares":14897,"price":18.22,"value":271423.34,"ownership":{"direct":true},"balance_after":110994,"source":{"system":"sec-edgar","filing":"0001214659-21-005926","document":"marketforms-52930.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465921005926/marketforms-52930.xml","form_type":"4"}},{"id":2767493,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-30T20:51:59.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":92365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option shall vest on March 13, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":92365,"derivative":{"exercise_price":33.78,"expiration_date":"2031-03-26","underlying":"Common Stock","underlying_shares":92365},"source":{"system":"sec-edgar","filing":"0001214659-21-003603","document":"marketforms-52123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465921003603/marketforms-52123.xml","form_type":"4"}},{"id":2767492,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-30T20:51:59.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":24866,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":96097,"source":{"system":"sec-edgar","filing":"0001214659-21-003603","document":"marketforms-52123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465921003603/marketforms-52123.xml","form_type":"4"}},{"id":2780728,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-17T21:00:21.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":8053,"price":38.2328,"value":307888.7384,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.975 to $38.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 368 shares of the Issuer's common stock acquired by the reporting person on March 15, 2021 pursuant to an employee stock purchase program."}],"balance_after":71231,"source":{"system":"sec-edgar","filing":"0001214659-21-003238","document":"marketforms-51916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465921003238/marketforms-51916.xml","form_type":"4"}},{"id":2903825,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-19T21:31:46.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":400,"price":33.285,"value":13314.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust in August 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.17 to $33.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1152595,"source":{"system":"sec-edgar","filing":"0001214659-21-000617","document":"marketforms-50963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465921000617/marketforms-50963.xml","form_type":"4"}},{"id":2903824,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-19T21:31:46.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":11053,"price":32.4031,"value":358151.4643,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust in August 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.04 to $33.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1152995,"source":{"system":"sec-edgar","filing":"0001214659-21-000617","document":"marketforms-50963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465921000617/marketforms-50963.xml","form_type":"4"}},{"id":2903823,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-19T21:31:46.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":3547,"price":31.6869,"value":112393.4343,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust in August 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1164048,"source":{"system":"sec-edgar","filing":"0001214659-21-000617","document":"marketforms-50963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465921000617/marketforms-50963.xml","form_type":"4"}},{"id":2903822,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-19T21:31:46.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":5149,"price":31.0991,"value":160129.2659,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust in August 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1167595,"source":{"system":"sec-edgar","filing":"0001214659-21-000617","document":"marketforms-50963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465921000617/marketforms-50963.xml","form_type":"4"}},{"id":2903821,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-19T21:31:46.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":9851,"price":30.6041,"value":301480.9891,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust in August 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1172744,"source":{"system":"sec-edgar","filing":"0001214659-21-000617","document":"marketforms-50963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465921000617/marketforms-50963.xml","form_type":"4"}},{"id":2910511,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-01-11T21:10:25.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest from the date of grant in quarterly increments of 6.25%."}],"balance_after":100000,"derivative":{"exercise_price":33.43,"exercise_date":"2021-04-07","expiration_date":"2031-01-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-21-001429","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390021001429/ownership.xml","form_type":"4"}},{"id":2974217,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-18T21:36:12.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":10366,"price":33,"value":342078.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust in August 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.93 to $33.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1182595,"source":{"system":"sec-edgar","filing":"0001214659-20-009726","document":"marketforms-50139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920009726/marketforms-50139.xml","form_type":"4"}},{"id":2974216,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-18T21:36:12.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":4634,"price":32.6,"value":151068.4,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust in August 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.93 to $32.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1192961,"source":{"system":"sec-edgar","filing":"0001214659-20-009726","document":"marketforms-50139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920009726/marketforms-50139.xml","form_type":"4"}},{"id":3004825,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-16T22:55:04.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":100,"price":43.01,"value":4301.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust in August 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1197595,"source":{"system":"sec-edgar","filing":"0001214659-20-008703","document":"marketforms-49861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/marketforms-49861.xml","form_type":"4"}},{"id":3004824,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-16T22:55:04.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":2099,"price":42.3247,"value":88839.5453,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust in August 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1197695,"source":{"system":"sec-edgar","filing":"0001214659-20-008703","document":"marketforms-49861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/marketforms-49861.xml","form_type":"4"}},{"id":3004823,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-16T22:55:04.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":3479,"price":41.3336,"value":143799.5944,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust in August 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.91 to $41.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1199794,"source":{"system":"sec-edgar","filing":"0001214659-20-008703","document":"marketforms-49861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/marketforms-49861.xml","form_type":"4"}},{"id":3004822,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-16T22:55:04.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":4218,"price":40.0689,"value":169010.6202,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust in August 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.82 to $40.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1203273,"source":{"system":"sec-edgar","filing":"0001214659-20-008703","document":"marketforms-49861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/marketforms-49861.xml","form_type":"4"}},{"id":3004821,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-16T22:55:04.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":5104,"price":39.4674,"value":201441.6096,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust in August 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.80 to $39.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1207491,"source":{"system":"sec-edgar","filing":"0001214659-20-008703","document":"marketforms-49861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/marketforms-49861.xml","form_type":"4"}},{"id":3024381,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-22T20:48:16.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":1911,"price":37.04,"value":70783.44,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust on August 18, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.71 to $37.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1212595,"source":{"system":"sec-edgar","filing":"0001214659-20-008039","document":"marketforms-49727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920008039/marketforms-49727.xml","form_type":"4"}},{"id":3024380,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-22T20:48:16.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":3200,"price":35.9591,"value":115069.12,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust on August 18, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.47 to $36.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1214506,"source":{"system":"sec-edgar","filing":"0001214659-20-008039","document":"marketforms-49727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920008039/marketforms-49727.xml","form_type":"4"}},{"id":3024379,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-22T20:48:16.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":9889,"price":34.755,"value":343692.195,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the Eric Schmidt 2017 Family Irrevocable Trust on August 18, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.34 to $35.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1217706,"source":{"system":"sec-edgar","filing":"0001214659-20-008039","document":"marketforms-49727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920008039/marketforms-49727.xml","form_type":"4"}},{"id":3103893,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T19:33:02.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":25318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One thirty-sixth (1/36th) of the shares subject to the option will vest on each monthly anniversary measured from June 17, 2020 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":25318,"derivative":{"exercise_price":36.57,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":25318},"source":{"system":"sec-edgar","filing":"0001567619-20-012442","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761920012442/doc1.xml","form_type":"4"}},{"id":3103892,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-19T19:33:02.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":7234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,234 Restricted Stock Units."}],"balance_after":7234,"source":{"system":"sec-edgar","filing":"0001567619-20-012442","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761920012442/doc1.xml","form_type":"4"}},{"id":3178889,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants to purchase common stock","published_at":"2020-04-09T20:37:05.000Z","date":"2020-04-09","kind":"other","acquired":false,"shares":12500,"price":9,"value":112500.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9,"exercise_date":"2019-05-14","expiration_date":"2024-05-14","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001213900-20-008907","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390020008907/ownership.xml","form_type":"4"}},{"id":3178888,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants to purchase common stock","published_at":"2020-04-09T20:37:05.000Z","date":"2020-04-09","kind":"other","acquired":false,"shares":32500,"price":6,"value":195000.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6,"exercise_date":"2018-12-03","expiration_date":"2023-12-03","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001213900-20-008907","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390020008907/ownership.xml","form_type":"4"}},{"id":3178887,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-09T20:37:05.000Z","date":"2020-04-09","kind":"other","acquired":true,"shares":12500,"price":9,"value":112500.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001213900-20-008907","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390020008907/ownership.xml","form_type":"4"}},{"id":3178886,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-09T20:37:05.000Z","date":"2020-04-09","kind":"other","acquired":true,"shares":32500,"price":6,"value":195000.0,"ownership":{"direct":true},"balance_after":87500,"source":{"system":"sec-edgar","filing":"0001213900-20-008907","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390020008907/ownership.xml","form_type":"4"}},{"id":3198877,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-20T20:36:55.000Z","date":"2020-03-18","kind":"grant","acquired":true,"shares":109600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option shall vest on March 13, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":109600,"derivative":{"exercise_price":18.22,"expiration_date":"2030-03-17","underlying":"Common Stock","underlying_shares":109600},"source":{"system":"sec-edgar","filing":"0001214659-20-002803","document":"marketforms-48392.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920002803/marketforms-48392.xml","form_type":"4"}},{"id":3198876,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-20T20:36:55.000Z","date":"2020-03-18","kind":"grant","acquired":true,"shares":30800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":78706,"source":{"system":"sec-edgar","filing":"0001214659-20-002803","document":"marketforms-48392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920002803/marketforms-48392.xml","form_type":"4"}},{"id":3201676,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-18T20:32:12.000Z","date":"2020-03-16","kind":"sale","acquired":false,"shares":300,"price":20.25,"value":6075.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.  This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 949 shares of the Issuer's common stock acquired by the reporting person on March 16, 2020 pursuant to an employee stock purchase program."}],"balance_after":47906,"source":{"system":"sec-edgar","filing":"0001214659-20-002735","document":"marketforms-48344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920002735/marketforms-48344.xml","form_type":"4"}},{"id":3201675,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-18T20:32:12.000Z","date":"2020-03-16","kind":"sale","acquired":false,"shares":5150,"price":19.6957,"value":101432.855,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.  This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.16 to $20.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":47257,"source":{"system":"sec-edgar","filing":"0001214659-20-002735","document":"marketforms-48344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920002735/marketforms-48344.xml","form_type":"4"}},{"id":3251861,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-24T22:14:54.000Z","date":"2020-02-20","kind":"other","acquired":false,"shares":237155,"price":25.3,"value":6000021.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person made a previous irrevocable commitment to contribute shares of the Issuer's common stock to an exchange fund in exchange for shares of the exchange fund.  The Issuer's common stock was valued at the closing price on February 19, 2020 of $25.30 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person made a previous irrevocable commitment to contribute shares of the Issuer's common stock to an exchange fund in exchange for shares of the exchange fund.  The Issuer's common stock was valued at the closing price on February 19, 2020 of $25.30 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust."}],"balance_after":1227595,"source":{"system":"sec-edgar","filing":"0001214659-20-001733","document":"marketforms-47856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465920001733/marketforms-47856.xml","form_type":"4"}},{"id":3592253,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-15T21:21:19.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":83500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option shall vest on the first anniversary of the grant date, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":83500,"derivative":{"exercise_price":26.89,"expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":83500},"source":{"system":"sec-edgar","filing":"0001209191-19-019762","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000120919119019762/doc4.xml","form_type":"4"}},{"id":3592252,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":112425,"kind":"person","name":"SCHMIDT ERIC THOMAS","position":1,"cik":"0001754403","reported_name":"SCHMIDT ERIC THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-15T21:21:19.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":49400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49400,"source":{"system":"sec-edgar","filing":"0001209191-19-019762","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000120919119019762/doc4.xml","form_type":"4"}}]}